The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency.
Dec 1, 2020
0
3
What does emergency use of a COVID-19 vaccine mean?
Nov 20, 2020
0
4
(HealthDay)—Forty-five potential vaccines for COVID-19 are being tested in human trials and many more are being tested in animals. Researchers are using several approaches to trigger an immune response against SARS-CoV-2, ...
Oct 30, 2020
0
2
The COVID-19 pandemic has led to new rules and expectations for clinical trials. Following guidance from federal agencies, institutions such as UT Southwestern adjusted clinical trial operations. To protect patient safety, ...
Oct 8, 2020
0
1
Over the past 2 decades, data submitted to the U.S. Food and Drug Administration (FDA) for new opioid approvals has lacked critical safety and efficacy information. During this timeframe, the FDA approved opioids on the basis ...
Sep 29, 2020
0
2
Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic ...
Aug 27, 2020
0
40
A comprehensive review of vaccine data over a 20-year period finds that vaccines are remarkably safe.
Jul 28, 2020
0
18
A new study of 1,443 medications found that three prescription drugs currently on the market caused unexpected changes in worms that could point to potential, unrecognized effects in humans.
Jul 27, 2020
0
122
Switzerland announced Thursday that COVID-19 patients beyond those on clinical trials could be given remdesivir, the first drug shown to be relatively effective in treating the new coronavirus.
Jul 2, 2020
0
3
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
Jun 20, 2020
0
28
